Literature DB >> 33264468

Colectomy rates for ulcerative colitis in England 2003-2016.

Guy Worley1,2, Alex Almoudaris1,2, Paul Bassett3,4, Jonathan Segal1,2, Ayesha Akbar2,3, Subrata Ghosh5, Paul Aylin6, Omar Faiz1,2.   

Abstract

BACKGROUND: Temporal trends in colectomy rate for ulcerative colitis (UC) are particularly relevant in the current era of published IBD standards and changing approach to salvage of acute severe disease. AIMS: To investigate temporal trends in colectomy for UC using English population data.
METHODS: The Hospital Episode Statistics (HES) were interrogated between 2003-2016 with two patient groups investigated independently. An 'emergency' cohort: emergency UC admission ≥ three days, age ≥18 and a 'total population' cohort: all English patients undergoing colectomy for UC. Mixed methods analyses were utilised.
RESULTS: Emergency cohort: 37 981 patients, 49% female, median age 46. The one- and three-year incidence of colectomy after acute admission was 0.17 and 0.21. Interrupted time series (ITS) analysis suggested reductions in colectomy rate of 4% per year after 2008 at 30 and 90 days following emergency admission, with no significant reduction ≥1 year. Mortality and laparoscopy rates improved when avoiding colectomy at index and emergency admissions; however, the proportion of emergency colectomies after salvage at index admission significantly increased during the study period. Total population cohort: 17 580 patients underwent colectomy for UC between 2003 and 2016, demonstrating a 3.1% annual reduction in total and elective colectomies after 2008, but no reduction in emergency colectomies.
CONCLUSION: Reductions in short-term colectomy rates after emergency admission for UC do not persist beyond one year. Emergency colectomy rates remain unchanged. Reduced rates are probably due to multi-modal improvements in IBD care. A lack of data regarding disease severity precludes further interpretation of appropriate medical salvage and timely surgery.
© 2020 John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 33264468     DOI: 10.1111/apt.16202

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  2 in total

1.  The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational study.

Authors:  Mohammed Deputy; Kapil Sahnan; Guy Worley; Komal Patel; Violeta Balinskaite; Alex Bottle; Paul Aylin; Elaine M Burns; Ailsa Hart; Omar Faiz
Journal:  Aliment Pharmacol Ther       Date:  2022-02-07       Impact factor: 9.524

2.  How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study.

Authors:  Yiyoung Kwon; Eun Sil Kim; Yon Ho Choe; Mi Jin Kim
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.